A compound represented by the formula (I) or a pharmacologically acceptable salt thereof is used as an activator of PPAR.
wherein each of R1 and R2 is hydrogen, C1-8 alkyl, C1-8 alkyl substituted with halogen, or the like; each of R3, R4, R5, and R6 is hydrogen, C1-8 alkyl, or the like; X is sulfur or the like; Y is oxygen, a bond, or the like; p is 0 or 1; A is oxygen, CH2, N-NH2, or the like; when p is 1, B is phenyl, which can have a substituent; when p is 0, B is a condensed ring such as benzisoxazole, which can have a substituent; m is an integer of 1 to 4; and n is an integer of 0 to 5.
由式 (I) 代表的化合物或其药理学上可接受的盐可用作
PPAR 的激活剂。
其中 R1 和 R2 各为氢、C1-8 烷基、被卤素取代的 C1-8 烷基或类似物;R3、R4、R5 和 R6 各为氢、C1-8 烷基或类似物;X 为
硫或类似物;Y 为氧、键或类似物;p 为 0 或 1;A 是氧、
CH2、N-NH2 或类似物;当 p 为 1 时,B 是苯基,可以有取代基;当 p 为 0 时,B 是缩合环,如苯并
异噁唑,可以有取代基;m 是 1 至 4 的整数;n 是 0 至 5 的整数。